Pulsed inotropic therapy in chronic congestive heart failure: A review of the literature

American Journal of Therapeutics

Volumn 7, Issue 6, 2000, Pages 375-380

  Woods, Timothy D ^a   Prisant, L Michael ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Dobutamine; Heart failure; Inotrope; Intravenous; Milrinone

Indexed keywords

CARDIOTONIC AGENT;

CONGESTIVE HEART FAILURE; DRUG EFFECT; DRUG PULSE THERAPY; HEART; HEART CONTRACTION; HUMAN; REVIEW; STIMULATION;

CARDIOTONIC AGENTS; HEART; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL CONTRACTION; PULSE THERAPY, DRUG; STIMULATION, CHEMICAL;

EID: 0034329208     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200007060-00006     Document Type: Article

References (4)

1. Massie BM, Shah NB: Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 1997;133:703-712.
2. Cohn JN, Archibald DG, Ziesche S, et al: Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of the Veterans Administration Cooperative Study. N Engl J Med 1986;314:1547-1552.
3. The CONSENSUS Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-1435.
4. The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.